Genetic variants in the gene encoding p21 protein (CDKN1A) may also participate in NAFLD progression, but once fibrosis develops, no further progress has been observed with some of its SNPs [142]. Here, CDKN1A is linked to metabolic dysfunction-associated steatotic liver disease.